Sonnet BioTherapeutics (SONN) Short Interest Ratio & Short Volume $2.98 +0.09 (+3.11%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Sonnet BioTherapeutics Short Interest DataSonnet BioTherapeutics (SONN) has a short interest of 66,200 shares, representing 3.92% of the float (the number of shares available for trading by the public). This marks a 218.27% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.37 million shares to cover all short positions.Current Short Interest66,200 sharesPrevious Short Interest20,800 sharesChange Vs. Previous Month+218.27%Dollar Volume Sold Short$299,886.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares680,000 sharesFloat Size1,690,000 sharesShort Percent of Float3.92%Today's Trading Volume45,437 sharesAverage Trading Volume1,370,473 sharesToday's Volume Vs. Average3% Short Selling Sonnet BioTherapeutics? Sign up to receive the latest short interest report for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSONN Short Interest Over TimeSONN Days to Cover Over TimeSONN Percentage of Float Shorted Over Time Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Sonnet BioTherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202466,200 shares $299,886.00 +218.3%3.9%0.2 $4.53 10/15/202420,800 shares $100,672.00 +61.2%3.4%0.8 $4.84 9/30/202412,900 shares $86,559.00 -62.8%2.0%0.5 $6.71 9/15/202434,700 shares $28,124.35 -21.9%0.7%0.3 $0.81 8/31/202444,400 shares $32,012.40 -32.4%0.9%0.3 $0.72 8/15/202465,700 shares $53,217.00 +53.2%1.3%0.5 $0.81 Get the Latest News and Ratings for SONN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sonnet BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202442,900 shares $33,676.50 +168.1%0.9%0.8 $0.79 7/15/202416,000 shares $14,123.20 -49.4%0.3%0.3 $0.88 6/30/202431,600 shares $29,625.00 -90.7%1.1%0.9 $0.94 6/15/2024338,600 shares $558,690.00 -1.7%12.0%9.6 $1.65 5/31/2024344,300 shares $540,551.00 -15.7%12.2%4.1 $1.57 5/15/2024408,400 shares $722,868.00 +2.1%14.5%4.2 $1.77 4/30/2024400,200 shares $708,354.00 -5.7%14.4%4 $1.77 4/15/2024424,200 shares $767,802.00 -6.2%15.3%4.3 $1.81 3/31/2024452,200 shares $841,092.00 -18.9%16.3%4.5 $1.86 3/15/2024557,500 shares $1.13 million +119.4%20.1%5.1 $2.02 2/29/2024254,100 shares $500,577.00 +9.5%9.1%2.5 $1.97 2/15/2024232,100 shares $378,323.00 +38.8%8.4%4.7 $1.63 1/31/2024167,200 shares $244,112.00 +2.0%6.0%3 $1.46 1/15/2024163,900 shares $219,626.00 +44.5%5.9%2.2 $1.34 12/31/2023113,400 shares $197,316.00 +21.2%4.1%1.5 $1.74 12/15/202393,600 shares $131,976.00 +49.5%3.4%1.3 $1.41 11/30/202362,600 shares $87,014.00 +18.1%2.4%0.9 $1.39 11/15/202353,000 shares $68,900.00 -11.5%2.0%0.7 $1.30 10/31/202359,900 shares $74,276.00 +24.5%2.5%0.7 $1.24 10/15/202348,100 shares $111,592.00 -9.3%3.3%0.7 $2.32 9/30/202353,000 shares $151,845.00 +59.6%3.7%0.7 $2.87 9/15/202333,200 shares $119,520.00 -1.2%2.3%0.4 $3.60 8/31/202333,600 shares $147,840.00 -94.1%2.3%0.3 $4.40 8/15/2023570,500 shares $186,610.55 +59.9%N/A0.1 $0.33 7/31/2023356,700 shares $118,638.42 -39.4%N/A0.1 $0.33 7/15/2023588,400 shares $255,306.76 -19.4%N/A0.1 $0.43 6/30/2023729,900 shares $357,651.00 -64.2%N/A0.2 $0.49 6/15/20232,040,000 shares $1.90 million -24.2%13.6%0.5 $0.93 5/31/20232,690,000 shares $1.38 million +441.9%15.7%0.9 $0.51 5/15/2023496,400 shares $111,044.68 -46.1%2.8%0.3 $0.22 4/30/2023921,700 shares $220,747.15 +255.7%5.0%0.9 $0.24 4/15/2023259,100 shares $94,571.50 +115.4%1.3%0.3 $0.37 3/31/2023120,300 shares $43,308.00 -45.2%0.6%0.2 $0.36 3/15/2023219,500 shares $122,963.90 -41.0%1.1%0.4 $0.56Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/2023372,200 shares $314,397.34 -30.7%1.9%0.8 $0.84 2/15/2023536,700 shares $520,545.33 +197.5%2.8%1.1 $0.97 1/31/2023180,400 shares $207,460.00 -46.7%2.4%0.2 $1.15 1/15/2023338,700 shares $477,567.00 +154.7%4.5%0.1 $1.41 12/30/2022133,000 shares $152,950.00 +830.1%1.8%0 $1.15 12/15/202214,300 shares $13,871.00 -96.0%0.2%0 $0.97 11/30/2022359,900 shares $359,900.00 +11.7%8.7%0.1 $1.00 11/15/2022322,300 shares $393,206.00 +125.4%7.8%0.1 $1.22 10/31/2022143,000 shares $275,990.00 -15.8%3.5%0 $1.93 10/15/2022169,800 shares $212,250.00 -74.0%4.1%0.5 $1.25 9/30/2022652,200 shares $958,734.00 +1,427.4%15.7%1.9 $1.47 9/15/202242,700 shares $135,700.60 -88.3%1.0%0.1 $3.18 8/31/2022363,800 shares $76,834.56 +52.7%N/A0.3 $0.21 8/15/2022238,300 shares $69,249.98 +181.4%N/A0.2 $0.29 7/31/202284,700 shares $23,233.21 -68.2%N/A0.1 $0.27 7/15/2022266,600 shares $78,993.58 +5.8%N/A0.2 $0.30 6/30/2022252,100 shares $70,588.00 -88.2%N/A0.1 $0.28 6/15/20222,130,000 shares $506,940.00 +122.6%N/A0.9 $0.24 5/31/2022956,900 shares $251,664.70 +10.5%N/A0.1 $0.26 5/15/2022866,100 shares $223,280.58 -36.3%N/A0.1 $0.26 4/30/20221,360,000 shares $412,896.00 -44.3%N/A0.2 $0.30 4/15/20222,440,000 shares $805,444.00 -11.0%N/A0.4 $0.33 3/31/20222,740,000 shares $1.03 million +464.8%N/A0.4 $0.38 3/15/2022485,100 shares $133,790.58 -40.5%N/A0.1 $0.28 2/28/2022814,800 shares $237,106.80 -7.9%N/A0.7 $0.29 2/15/2022884,800 shares $272,518.40 +275.6%N/A0.7 $0.31 1/31/2022235,600 shares $77,041.20 -17.6%N/A0.2 $0.33 1/15/2022285,800 shares $100,030.00 -17.0%N/A0.2 $0.35 12/31/2021344,500 shares $142,312.95 -58.7%N/A0.2 $0.41 12/15/2021834,300 shares $420,070.05 -26.2%N/A0.3 $0.50 11/30/20211,130,000 shares $642,744.00 +3.7%N/A0.3 $0.57 11/15/20211,090,000 shares $660,540.00 +123.0%N/A0.2 $0.61 10/29/2021488,700 shares $313,452.18 -17.8%N/A0 $0.64 10/15/2021594,200 shares $389,438.68 +51.0%N/A0.1 $0.66 9/30/2021393,500 shares $238,461.00 -92.3%N/A0 $0.61 9/15/20215,120,000 shares $3.22 million +5.4%N/A0.5 $0.63 8/31/20214,860,000 shares $3.35 million +46.0%N/A0.6 $0.69 8/13/20213,330,000 shares $3.25 million +2.8%N/A0.7 $0.98 7/30/20213,240,000 shares $3.43 million +53.6%N/A3.6 $1.06 7/15/20212,110,000 shares $2.68 million +48.6%10.8%1.7 $1.27 6/30/20211,420,000 shares $2.24 million +86.4%7.3%1.2 $1.58 6/15/2021761,700 shares $1.16 million +44.8%3.9%0.7 $1.52 5/28/2021526,000 shares $815,300.00 -39.0%2.7%0.5 $1.55 5/14/2021861,800 shares $1.26 million +194.1%4.5%0.7 $1.46 4/30/2021293,000 shares $588,930.00 -12.8%1.8%0.2 $2.01 4/15/2021336,000 shares $705,600.00 -12.5%2.1%0.3 $2.10 3/31/2021383,900 shares $796,592.50 -54.5%2.4%0.4 $2.08 3/15/2021843,100 shares $2.10 million +44.4%5.3%0.8 $2.49 2/26/2021583,800 shares $1.38 million -20.2%3.7%0.5 $2.37 2/12/2021731,500 shares $2.21 million -14.7%4.7%0.7 $3.02Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 1/29/2021857,900 shares $2.31 million -3.2%5.6%0.9 $2.69 1/15/2021886,200 shares $2.20 million No Change5.8%1.1 $2.48 SONN Short Interest - Frequently Asked Questions What is Sonnet BioTherapeutics' current short interest? Short interest is the volume of Sonnet BioTherapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 66,200 shares of SONN short. 3.92% of Sonnet BioTherapeutics' shares are currently sold short. Learn More on Sonnet BioTherapeutics' current short interest. What is a good short interest percentage for Sonnet BioTherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.92% of Sonnet BioTherapeutics' floating shares are currently sold short. Is Sonnet BioTherapeutics' short interest increasing or decreasing? Sonnet BioTherapeutics saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 66,200 shares, an increase of 218.3% from the previous total of 20,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Sonnet BioTherapeutics' float size? Sonnet BioTherapeutics currently has issued a total of 680,000 shares. Some of Sonnet BioTherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sonnet BioTherapeutics currently has a public float of 1,690,000 shares. How does Sonnet BioTherapeutics' short interest compare to its competitors? 3.92% of Sonnet BioTherapeutics' shares are currently sold short. Here is how the short interest of companies compare to Sonnet BioTherapeutics: Alterity Therapeutics Limited (0.04%), Coeptis Therapeutics Holdings, Inc. (0.52%), Galecto, Inc. (0.42%), Biora Therapeutics, Inc. (4.76%), Syros Pharmaceuticals, Inc. (6.35%), ABVC BioPharma, Inc. (1.77%), Brainstorm Cell Therapeutics Inc. (2.27%), Edesa Biotech, Inc. (0.75%), Eyenovia, Inc. (2.48%), GT Biopharma, Inc. (0.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Sonnet BioTherapeutics stock? Short selling SONN is an investing strategy that aims to generate trading profit from Sonnet BioTherapeutics as its price is falling. SONN shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sonnet BioTherapeutics? A short squeeze for Sonnet BioTherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SONN, which in turn drives the price of the stock up even further. How often is Sonnet BioTherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SONN, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Alterity Therapeutics Short Squeeze Coeptis Therapeutics Short Squeeze Galecto Short Squeeze Biora Therapeutics Short Squeeze Syros Pharmaceuticals Short Squeeze ABVC BioPharma Short Squeeze Brainstorm Cell Therapeutics Short Squeeze Edesa Biotech Short Squeeze Eyenovia Short Squeeze GT Biopharma Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SONN) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredTrump Can’t Stop This Crisis—Your Savings Are in JeopardyA lot of people are betting on Trump's re-election to solve everything. They think that if he wins, the econom...Golden Crest | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
